Commemorative Series No. 2 · The Drug Money
OUTSPENTNo. 18/54
Pat
Roberts
U.S. Senate · R-KS
Taken from pharma & insurers
$69,850
H.R.1 · Medicare drug-price ban · 2003tap to flip ⤺
WHO THEY WORK FORNo. 18/54
Pharma & Health$69,600
Insurers & HMOs$250
Banned Medicare from negotiating drug prices for 19 years. Once it could (2024), prices fell 38–79%. · 108-1-459OUTSPENT
Card 18 of 54 · tap the card to see who they work for
Beyond the check
The check is only the part you can see.
They took
$69,850
The industry spent on the bill
$116M
on drug-industry lobbying in 2003, about ten lobbyists for every senator
Through the leadership PAC
His leadership PAC took money from the banks, drug makers, an insurer and a card lender (American Bankers Assn, Goldman Sachs, Pfizer, Anthem, Synchrony), outside his campaign account.
Source: FEC; ProPublica Itemizer
The industry figure is lobbying spent on the bill, not a payment to this senator. Source: Public Citizen (2004); Center for Public Integrity. Everything here is documented public record; nothing alleges an illegal act.
★ Hall of Shame
Roberts voted with the money in more than one set:
Don't recognize a logo? Here's the key.
Pharma & Health$69,600
Amgen$19,850
PhRMA$16,000
Johnson & Johnson$14,800
Pfizer$8,750
Merck$7,300
Bristol Myers Squibb$2,500
AbbVie$400
Insurers & HMOs$250
Humana$250